DD — DuPont de Nemours, Inc.
NYSE
Q1 2026 Earnings Call Summary
May 5, 2026
DuPont Q1 2026 Earnings Call Summary
1. Key Financial Results and Metrics
- Net Sales: $1.7 billion, up 4% year-over-year, driven by 2% organic growth and a 2% currency benefit.
- Operating EBITDA: $414 million, a 15% increase year-over-year, with a margin of 24.6%, up 230 basis points.
- Adjusted EPS: $0.55, a 53% increase year-over-year; on a pro forma basis, EPS was up 20%.
- Free Cash Flow: Transaction-adjusted free cash flow of $147 million, with a conversion rate of 65%.
- Segment Performance:
- Healthcare & Water Technologies: Net sales of $806 million, up 6% (3% organic growth).
- Diversified Industrials: Net sales of $875 million, up 3% (flat organic growth).
2. Strategic Updates and Business Highlights
- DuPont completed the divestiture of its Aramids business on April 1, 2026, and plans to launch a $275 million accelerated share repurchase.
- The company issued its 2026 sustainability report and set new 2035 sustainability goals focusing on sustainable innovation and operational resilience.
- Continued investment in R&D and digital capabilities, including a collaboration with an AI-driven platform to enhance product development.
- The company is implementing its 80/20 strategy in Diversified Industrials to enhance margins without significant top-line impact.
3. Forward Guidance and Outlook
- Full-Year 2026 Guidance:
- Net sales expected to be approximately $7.185 billion, reflecting a 4% organic growth.
- Operating EBITDA projected at $1.745 billion.
- Adjusted EPS guidance raised to $2.35 - $2.40 per share.
- Q2 2026 Guidance:
- Estimated net sales of about $1.8 billion and operating EBITDA of about $430 million.
- Anticipated organic sales growth of 3% year-over-year.
4. Bad News, Challenges, or Points of Concern
- Middle East Conflict: Logistics disruptions due to the ongoing conflict impacted sales, particularly in the water business, with $10 million in sales unable to ship in Q1. The company is cautious about potential macroeconomic headwinds.
- Construction Market Weakness: Continued softness in construction markets is expected to result in flat growth for the year.
- Stranded Costs: Approximately $30 million in stranded costs are being managed, with $10 million expected to be removed this year.
- Pricing Pressures: Increased input costs are anticipated, with the company implementing price increases to offset these costs.
5. Notable Q&A Insights
- 80/20 Strategy: The company is progressing well, with expectations for margin improvements but minimal top-line impact.
- Water Business: Despite the challenges, the company expects to maintain mid-single-digit growth in the water segment for the year, with large projects anticipated in the second half.
- Healthcare Growth: Strong demand driven by aging populations and healthcare access is expected to continue supporting growth in the healthcare segment.
- Operational Improvements: Strong productivity gains contributed to margin expansion, with a mix of favorable product mix and operational efficiencies.
- Future M&A: The company remains open to acquisitions to enhance its portfolio, particularly in healthcare, while maintaining a disciplined approach to capital allocation.
Overall, DuPont's Q1 2026 results reflect a strong operational start to the year, with solid financial performance and strategic initiatives aimed at long-term growth, despite facing challenges from geopolitical tensions and market softness in certain sectors.
